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Abstract
High saturated and trans fatty acid intake, the typical dietary pattern of Western populations, favors a proinflammatory status 
that contributes to generating insulin resistance (IR). We examined whether the consumption of these fatty acids was associated 
with IR and inflammatory markers. In this cross-sectional study, 127 non-diabetic individuals were allocated to a group without 
IR and 56 to another with IR, defined as homeostasis model assessment-IR (HOMA-IR) >2.71. Diet was assessed using 24-h 
food recalls. Multiple linear regression was employed to test independent associations with HOMA-IR. The IR group presented 
worse anthropometric, biochemical and inflammatory profiles. Energy intake was correlated with abdominal circumference and 
inversely with adiponectin concentrations (r = -0.227, P = 0.002), while saturated fat intake correlated with inflammatory mark-
ers and trans fat with HOMA-IR (r = 0.160, P = 0.030). Abdominal circumference was associated with HOMA-IR (r = 0.430, P 
< 0.001). In multiple analysis, HOMA-IR remained associated with trans fat intake (β = 1.416, P = 0.039) and body mass index 
(β = 0.390, P < 0.001), and was also inversely associated with adiponectin (β = -1.637, P = 0.004). Inclusion of other nutrients 
(saturated fat and added sugar) or other inflammatory markers (IL-6 and CRP) into the models did not modify these associations. 
Our study supports that trans fat intake impairs insulin sensitivity. The hypothesis that its effect could depend on transcription 
factors, resulting in expression of proinflammatory genes, was not corroborated. We speculate that trans fat interferes predomi-
nantly with insulin signaling via intracellular kinases, which alter insulin receptor substrates.
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High energy and high fat intake characterizes the diet of 
numerous Western populations. Particularly, the deleterious 
role of excessive saturated fatty acid (SFA) intake on the 
cardiovascular system has been consistently demonstrated. 
When combined with physical inactivity, these habits con-
tribute to the accumulation of body fat, which generates a 
pro-inflammatory status. Several lines of evidence support 
the notion that SFA intake is the main trigger of inflammation 
in white adipose tissue (1). 
Adipocytes play a major role in energy balance, immune 
function and homeostasis of glucose and lipid metabo-
lism (2). Excessive SFA consumption leads to adipocyte 
hypertrophy and dysfunction, inducing the secretion of 
inflammatory factors, which results in a status of chronic 
low-grade inflammation (3) and is the pathophysiological 
basis for metabolic and cardiovascular diseases (2). In 
addition to SFA, trans fatty acid intake is also associated 
with metabolic disturbances (4). 
Hypertrophic adipocytes and macrophages are re-
sponsible for the increased expression of pro-inflammatory 
genes and secretion of cytokines such as interleukins and 
tumor necrosis factor alpha (TNF-α). The latter was the first 
adipocytokine found to be directly associated with insulin 
resistance (5,6). 
Obesity-induced cytokine secretion (TNF-α, interleukins) 
promotes an increase in hepatic synthesis of C-reactive 
protein (CRP), whose concentration has been used to as-
sess the risk of cardiovascular disease as well as type 2 
diabetes mellitus. Conversely, adiponectin concentration 
has been associated with protective cardiometabolic ef-
fects (2). It is possible that the determination of circulating 
levels of TNF-α, interleukins, CRP, and adiponectin may 
enhance the knowledge of the pathophysiological events 
linking SFA consumption and insulin resistance induction. 
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It was previously found that SFA stimulate intracellular in-
sulin signaling via the nuclear factor-ĸB (NF-ĸB), negatively 
influencing the translocation of glucose transporters to the 
plasma membrane (3). 
In addition to the deleterious impact of dietary SFA on 
metabolism and the cardiovascular system (4,7), prospec-
tive studies have reported an association of trans fatty acid 
intake with increased risk of type 2 diabetes mellitus (8). In 
contrast, diets rich in unsaturated fatty acids - such as the 
Mediterranean diet - have been shown to have beneficial 
effects against cardiovascular events (9). Such evidence 
elucidating the role of the consumption of different fatty acids 
in insulin sensitivity is relevant to orient health policies for 
populations at cardiometabolic risk (1). Another lifestyle fac-
tor of relevance for cardiometabolic homeostasis is physical 
activity. Inactivity is considered to be a major cardiovascular 
risk factor, while regular physical activity improves glucose 
and lipid metabolism (3,4,10,11).
Since the main causes of mortality are adiposity-related 
diseases (12-14), it is desirable to understand how daily 
habits influence their pathophysiologic chain. Little data 
are available concerning the association of fatty acid intake 
with metabolic disturbances, adjusted for physical activity, 
mediated by inflammation and insulin resistance, in Brazil-
ian population samples. We hypothesized that, similar to 
the role of SFA in insulin resistance, trans fatty acid intake 
may also contribute to the deterioration of insulin sensitiv-
ity, which may be mediated by proinflammatory markers. 
Therefore, the objective of the present study was to assess 
the associations of saturated or trans fatty acid intake with 
insulin resistance. 
Material and Methods
This cross-sectional study included individuals at high 
cardiometabolic risk, selected for an 18-month preven-
tion program of type 2 diabetes mellitus, conducted at 
the Health Center of the Faculdade de Saúde Pública, 
Universidade de São Paulo, Brazil. The local Research 
Ethics Committee approved the research protocol and 
all participants gave written informed consent. Of 438 
individuals screened between 2008 and 2009, 230 were 
eligible and 183 agreed to participate. Among those who 
did not agree to participate there was a predominance of 
men; however, non-participants did not differ from par-
ticipants in terms of sociodemographic, anthropometric 
or metabolic variables. Their basal dietary, clinical and 
laboratory data were analyzed. Inclusion criteria were 
adults aged 18 to 69 years with prediabetic conditions 
(impaired glucose tolerance or impaired fasting glycemia) 
(15) or with metabolic syndrome without diabetes, defined 
according to the International Diabetes Federation (16). 
Individuals with a medical history of neurological or psy-
chiatric disturbances, thyroid, liver, renal, and infectious 
diseases were excluded. 
Data collection
Trained staff collected dietary, physical activity and clini-
cal data. Food intake was assessed by means of three 24-h 
dietary recalls applied on non-consecutive days. The mean 
energy and macronutrient intakes of each individual were 
calculated. Physical activity was evaluated using the long 
version of the international physical activity questionnaire 
(17) and reported as minutes per week. 
Height was measured using a fixed stadiometer and 
weight was measured on a Filizola digital scale with the 
subjects wearing light clothing and no shoes. Body mass 
index (BMI) was subsequently calculated. Abdominal cir-
cumference was measured at the midpoint between the 
bottom of the rib cage and above the top of the iliac crest 
during minimal respiration. Percent body fat was estimated 
with a single-frequency bioimpedance analyzer (RJL Sys-
tems Inc., model Quantum II, USA). Tetrapolar placement 
of electrodes was used and individuals’ weight, height, age 
and gender were entered into the instrument for analysis 
with the measured bioelectrical impedance to calculate body 
composition based on manufacturer equations.
Blood pressure was measured at rest in the sitting 
position, 3 times at 5-min intervals with an automatic blood 
pressure device (Omron HEM-712C, Omron Health Care, 
USA). The average of the last 2 recorded measurements 
was used for analysis. 
Participants were submitted to a 75-g oral glucose toler-
ance test and venous blood samples were obtained for sev-
eral determinations. Categories of glucose tolerance were 
defined according to American Diabetes Association criteria 
(15). Plasma glucose and lipoproteins were immediately 
determined in the local laboratory using routine methods. 
Aliquots were frozen at -80°C for further determinations of 
inflammatory markers and hormones. Ultra-sensitive CRP, 
interleukin-6 (IL-6) and TNF-α were determined by an immu-
noenzyme chemiluminescent assay (Immulite, Diagnostic 
Products Corporation, USA). Insulin was determined by an 
immunometric assay using a quantitative chemiluminescent 
kit (AutoDelfia, Perkin Elmer Life Sciences Inc., USA) and 
adiponectin by an enzyme-linked immunosorbent assay 
(Linco Research, USA). Homeostasis model assessment 
was used to assess insulin resistance (HOMA-IR) (12). 
Insulin resistance was defined using the HOMA-IR cut-off 
value of 2.71, based on a previous study conducted on a 
similar Brazilian sample (18).
Statistical analysis
Dietary, physical activity, clinical and inflammatory data 
are reported as means ± SD or percentages. Nutrient intake 
is reported in grams and/or percent of total energy intake. 
Dietary data were adjusted according to the method of Wil-
lett and Stampfer (19) and processed using the Nutrition 
Data System® software (Minnesota Nutrition Coordinating 
Center, USA). Normality of variables was tested with the 
Kolmogorov-Smirnov test and those that were not normally 
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distributed were log-transformed. The Student 
t-test (or a non-parametric equivalent) was 
used for comparisons between categories. 
Frequencies were compared by the chi-square 
test. Pearson’s coefficient was used to test cor-
relations between variables. In stepwise linear 
regression analysis, the HOMA-IR index was 
the dependent variable. Variables showing a P 
value <0.20 in univariate analysis were selected 
for entry into the multiple model. Fatty acid 
intake was the independent variable of main 
interest, adjusted for age, gender, BMI, and 
total physical activity. Inflammatory markers 
(IL-6, adiponectin and CRP) were included to 
examine the influence of the inflammatory pro-
cess on insulin resistance. HOMA-IR, trans fatty 
acid intake, physical activity, and adiponectin 
concentration were log-transformed.
All analyses were conducted using SPSS 
version 17.0 for Windows (SPSS Inc., USA). 
A P value of <0.05 was considered to be 
significant. 
Results
In the study sample of 183 individuals, 121 
(66%) were women, mean age was 55.7 ± 12.3 
years and mean HOMA-IR values were 2.50 ± 
1.77. Participants were divided into 2 groups 
according to the cut-off value of HOMA-IR, with 
127 individuals allocated to the group without 
insulin resistance and 56 to the group with 
insulin resistance (30.6%). As expected, mean 
HOMA-IR values differed markedly between the 
groups with and without insulin resistance 4.49 
± 1.88 vs 1.62 ± 0.64, P < 0.001, respectively). 
Comparisons of mean dietary and clinical data 
are shown in Tables 1 and 2. Groups did not 
differ in energy or nutrient consumption. Insulin-
resistant individuals spent less time performing 
physical activity, had lower body adiposity, but 
similar blood pressure levels. 
Mean HDL cholesterol and adiponectin 
values were lower, and IL-6 concentration was 
higher, in the insulin-resistant group compared 
to the group without insulin resistance (Table 
2). Groups did not differ significantly concerning 
other laboratory variables. 
Significant correlation coefficients were 
found between habits, anthropometric mea-
surements, biomarkers, and HOMA-IR. Energy 
intake and abdominal circumference were cor-
related (r = 0.191, P = 0.010). Energy (r = -0.227; 
P = 0.002) and omega-6 polyunsaturated fatty 
acid (r = -0.172, P = 0.020) intakes were in-
Table 1. Dietary, physical activity, and clinical data of individuals stratified ac-
cording to the presence of insulin resistance (IR). 
 Without IR (N = 127) With IR (N = 56)
Intake
Energy (kcal) 1769.3 ± 644.5 1909.1 ± 859.1
Carbohydrate# (g) 210.6 ± 32.8 213.9 ± 36.9
Protein# (g) 77.6 ± 18.5 77.4 ± 17.6
Total fat# (g) 60.4 ± 13.0 59.3 ± 13.6
Saturated fat# (g) 18.8 ± 6.2 18.3 ± 5.1
Monounsaturated fat# (g) 20.9 ± 5.7 20.5 ± 5.9
Polyunsaturated fat# (g) 15.4 ± 4.5 15.6 ± 4.4
Omega 6 fatty acids# (g) 13.60 ± 4.04 13.66 ± 3.97
Omega 3 fatty acids# (g) 1.84 ± 0.57 1.99 ± 0.67
Omega 6/omega 3 ratio 7.67 ± 1.52 7.45 ± 1.15
Trans fatty acids# (g) 3.25 ± 2.23 3.40 ± 2.35
Total fiber# (g) 15.5 ± 7.1 14.6 ± 5.7
Total sugar# (g) 75.1 ± 25.0 79.8 ± 27.4
Added sugar# (g) 38.5 ± 21.4 39.8 ± 22.2
Total physical activity (min/week) 228.3 ± 239.3 138.5 ± 100.2*
Leisure physical activity (min/week) 46.1 ± 75.4 19.9 ± 41.6
Body mass index (kg/m2) 29.5 ± 5.1 33.9 ± 6.1*
Abdominal circumference (cm) 97.9 ± 11.0 108.9 ± 13.5*
Fat mass (%) 32.8 ± 8.8 38.2 ± 9.2*
Systolic blood pressure (mmHg) 135.5 ± 20.3 136.1 ± 17.8
Diastolic blood pressure (mmHg) 82.2 ± 10.3 84.0 ± 10.3
Data are reported as means ± SD. #Adjusted according to Willett and Stampfer 
(19). *P < 0.05 compared to without IR (Student t-test for independent sam-
ples).
Table 2. Laboratory variables of individuals stratified according to the presence 
of insulin resistance (IR).
 
 Without IR (N = 127) With IR (N = 56)
Fasting plasma glucose (mg/dL) 96.9 ± 11.3 104.5 ± 10.2*
Post-load plasma glucose (mg/dL) 115.0 ± 26.9 125.8 ± 27.3*
Triglycerides (mg/dL) 144.3 ± 60.7 165.9 ± 82.7
Fasting insulin (μIU/mL) 6.89 ± 2.87 17.60 ± 7.48*
Total cholesterol (mg/dL) 202.1 ± 37.9 192.2 ± 50.6
HDL cholesterol (mg/dL) 43.4 ± 11.5 39.6 ± 11.9*
LDL cholesterol (mg/dL) 129.0 ± 35.2 119.2 ± 45.0
VLDL cholesterol (mg/dL) 28.5 ± 11.3 32.2 ± 15.0
Leukocytes (N/mm3) 6606 ± 1744 7065 ± 1745
Interleukin-6 (pg/mL) 2.77 ± 3.10 3.79 ± 3.33*
C-reactive protein (mg/dL) 0.48 ± 0.52 0.60 ± 0.59
Adiponectin (ng/mL) 16.2 ± 15.4 11.3 ± 6.9*
TNF-α (ng/mL) 12.5 ± 6.5 12.4 ± 7.1
Data are reported as means ± SD. TNF-α = tumor necrosis factor alpha. 
*P < 0.05 compared to without IR (Student t-test for independent samples).
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versely correlated with adiponectin concentration. 
Saturated fat intake was correlated with IL-6 levels 
(r = 0.172, P = 0.025), leukocyte count (r = 0.153, 
P = 0.041), and added sugar to CRP (r = 0.210, P 
= 0.005). Fat mass also showed a correlation with 
CRP (r = 0.419, P < 0.001; Figure 1, Panel B).
HOMA-IR was correlated with several variables 
(Figure 1): physical activity (r = -0.168, P = 0.038), 
trans fatty acid intake (r = 0.160, P = 0.030), abdomi-
nal circumference (r = 0.430, P < 0.001), leukocyte 
count (r = 0.397, P = 0.005), and adiponectin con-
centrations (r = -0.288, P < 0.001). 
Independent associations with HOMA-IR in mul-
tiple linear regression analysis are shown in Table 3. 
The final model revealed that HOMA-IR was independently 
associated with trans fatty acid intake (β = 1.416, P = 
0.039) and BMI (β = 0.390, P < 0.001), and also inversely 
associated with adiponectin (β = -1.637, P = 0.004), after 
Figure 1. Correlation of HOMA-IR with total physical activity (Panel A), abdominal circumference (Panel B), leukocyte count (Panel 
C), and trans fatty acid intake (Panel D). HOMA-IR = homeostasis model assessment-insulin resistance.
Table 3. Final linear regression model for the association with HOMA-
IR.
 β 95% confidence interval P
Trans fatty acid intake#  1.416  1.016 to 1.820   0.039
Adiponectin# -1.637  -2.203 to -1.164   0.004
Age  0.051 -0.002 to 0.005   0.510
Physical activity# -1.180 -1.426 to 1.125   0.325
Body mass index  0.390  0.012 to 0.026 <0.001
#Anti-log-transformed values. HOMA-IR = homeostasis model assess-
ment-insulin resistance.
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adjustment for age, gender and physical activity. Inclusion 
of other nutrients such as saturated fat or added sugar or 
other inflammatory markers (IL-6 and CRP) in the models 
did not modify these associations.
Discussion
The present study contributes to the knowledge about 
the pathophysiologic relationship between certain dietary 
habits - particularly fatty acid intake - and insulin resistance. 
HOMA-IR was used to express insulin resistance and 
its cut-off value was obtained in a Brazilian sample with 
similar sociodemographic and clinical characteristics as 
the present sample (18). The cut-off of 2.71 does not differ 
markedly from others previously proposed (20). Since our 
study sample had risk factors for type 2 diabetes mellitus, 
a considerable proportion of insulin-resistant individuals 
was expected (30.6%). Several findings indicate that this 
value is adequate to identify insulin resistance; this subset 
showed higher body adiposity and plasma concentrations 
of glucose and IL-6, as well as lower concentrations of HDL 
cholesterol and adiponectin, typical abnormalities found in 
metabolic syndrome. 
The independent association of trans fatty acid intake 
and HOMA-IR was statistically significant in our study, al-
though the clinical relevance of this finding requires further 
investigation. The deleterious role of saturated and trans 
fatty acids in glucose and lipid metabolism has been con-
sistently demonstrated (3,4,7). This effect is due at least in 
part to increased body fatness, since hypertrophic adipo-
cytes and infiltrating macrophages are important sources 
of cytokines - such as TNF-α and IL-6 - which cause the 
deterioration of insulin sensitivity. The total fat intake found 
in our sample (approximately 30% of total energy intake) is 
comparable to levels reported in other Western populations 
(21). In crude analysis, total fat intake was not correlated 
with body adiposity, although the latter was shown to be 
associated with inflammatory markers (percent of fat mass 
with CRP) and insulin resistance (abdominal circumference 
with HOMA-IR). Interestingly, saturated fat consumption 
seemed to be correlated with IL-6 and leukocyte count, a 
fact that was not confirmed after adjustment. The ability of 
certain nutrients, such as fatty acids, to penetrate through 
the lipoprotein membrane and to induce gene expression 
has been clearly demonstrated (7,22).
This set of findings is coherent with the statement that 
obesity is a condition involving inflammation and insulin 
resistance. Evidence from animal models has shown that 
inflammatory cytokines cause intracellular abnormalities 
such as activation of IkB kinase (IKK) and c-Jun N-terminal 
kinase (JNK) and increased serine phosphorylation of insu-
lin receptor substrate 1, which inhibit insulin signaling and 
glucose transport, generating insulin resistance (23,24). Our 
data may suggest that these processes, inflammation and 
insulin resistance, coexist in the participants of this study. 
A direct correlation of HOMA-IR with leukocyte count and 
an inverse correlation of HOMA-IR with adiponectin are 
consistent with the hypothesis that intracellular inflamma-
tory factors contribute to inducing insulin resistance (3,16). 
Low circulating levels of adiponectin have been described 
within the spectrum of metabolic syndrome (25). Although 
associations with pro-inflammatory factors were not sup-
ported by our study, the detection of an independent inverse 
association of HOMA-IR with adiponectin is relevant con-
sidering its cardioprotective effect. 
Using multiple linear regression, we investigated 
whether saturated and trans fatty acids, independent of their 
impact on body adiposity, could contribute to the generation 
of inflammation and the deterioration of insulin sensitivity. 
In animal models, a high-fat diet induces endoplasmic 
reticulum stress, which activates IKK and JNK, thereby 
impairing insulin signaling (24). The gut microbiota of obese 
individuals or those consuming a high content of these fatty 
acids contains a predominance of Gram-negative bacteria 
rich in lipopolysaccharides (LPS). LPS are recognized by 
Toll membrane receptors in the circulation (endotoxemia), 
activating these kinases to generate insulin resistance, as 
well as NFĸB, which result in the expression of inflamma-
tory genes. Similar to LPS, saturated fatty acids are also 
recognized by membrane receptors triggering proinflam-
matory signaling pathways (26). 
A strength of the present study was the availability of 
physical activity data; this practice could introduce a poten-
tial confounder in the analysis of the relationship of dietary 
factors and metabolic abnormalities. Exercise enhances 
glucose uptake by stimulating glucose transporter type 4 
translocation to the plasma membrane, independently of 
insulin (27). However, the level of physical activity was not 
associated with HOMA-IR in the present study. This lack 
of association may be attributed at least in part to the low 
frequency of physical activity practiced by our sample. 
Adjustment for physical activity did not alter the results 
of HOMA-IR with nutrients obtained from the regression 
analysis. 
The crude analysis seemed to support previous 
evidence that saturated fatty acid intake could induce a 
proinflammatory status, but in adjusted analysis only trans 
fatty acids were independently associated with insulin re-
sistance. Considering that foods rich in trans fat may have 
a high sugar content, we tested whether the inclusion of 
added sugar could be a confounder in our analysis of the 
association with HOMA-IR. However, added sugar proved 
not to influence the strength of the association of interest. 
Considering the hypothesis that fatty acid intake may 
impair inulin sensitivity indirectly via the expression of 
inflammatory genes (TNF-α and interleukins), IL-6 or CRP 
and adiponectin concentrations were selected for input 
to the regression model. Adiponectin remained inversely 
associated with HOMA-IR, a finding consistent with its 
expected protective effects (2), but IL-6 or CRP did not. 
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Since inflammatory markers did not modify the associa-
tion of trans fatty acid intake with HOMA-IR, our results 
did not support the hypothesis that trans fatty acids can 
generate insulin resistance by inducing proinflammatory 
cytokine expression. These findings conflict with the results 
of other studies showing that NF-ĸB is activated by trans 
fatty acid (28). 
Our study has limitations. First, the design is not ap-
propriate to investigate causal relationships and the rate of 
losses was relatively high. Second, there was a limitation 
inherent to the tool used for assessing diet; despite extensive 
use of 24-h food recalls, three recalls may not be sufficiently 
sensitive to quantify nutrient intake; additionally, insulin 
resistance develops over the long-term while food recalls 
reflect recent habits. This aspect may have precluded the 
detection of the previously reported association of saturated 
fat intake with insulin resistance (7). 
The finding of an association of trans fatty acid intake 
with HOMA-IR corroborates the assumption that this nutri-
ent could play a role in the generation of insulin resistance, 
but not necessarily by stimulating inflammatory genes. We 
speculate that trans fatty acids should predominantly influ-
ence insulin sensitivity via activation of intracellular kinases, 
which alter insulin receptor substrates. However, activation 
of transcription factors for the expression of proinflammatory 
genes, contributing to reduced glucose uptake, cannot be 
excluded. Studies with a suitable design and more accurate 
tools for measuring long-term food consumption are desir-
able to refine future investigations of these associations.
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